| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 01/05/2011 | EP1365778B1 Treating pulmonary disorders with gaseous agent causing repletion of gsno |
| 01/05/2011 | EP1085862B1 Treatment of an autoimmune disease |
| 01/05/2011 | CN101939021A Non-immunosuppressive cyclosporin for the treatment of muscular dystrophy |
| 01/05/2011 | CN101939013A Therapeutic agent for fibromyalgia syndrome and therapeutic agent for pain due to vascular smooth muscle spasm |
| 01/05/2011 | CN101507770B Traditional Chinese medicine composite for treating horse spasm hernia |
| 01/04/2011 | US7863327 Chemopreventative treatment of diseases such as cancer, Alzheimer's disease, Parkinson's disease, inflammatory bowel disease, and multiple sclerosis |
| 01/04/2011 | CA2587579C Storage-stable aqueous composition comprising a magnesium compound and l-carnitine |
| 01/04/2011 | CA2491871C Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 01/04/2011 | CA2429312C Novel pyridine-substituted pyrazolopyridine derivatives |
| 01/04/2011 | CA2404128C Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 01/04/2011 | CA2306875C Nutritional supplement for cerebral metabolic insufficiencies |
| 01/04/2011 | CA2306093C Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 12/30/2010 | US20100331343 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| 12/30/2010 | US20100331304 Compounds Which Modulate The CB2 Receptor |
| 12/30/2010 | US20100331265 Methods for the prevention and treatment of burn injuries and secondary complications |
| 12/30/2010 | US20100331261 Use of alpha-1-antitrypsin for the preparation of drugs for the treatment of chronic fatigue syndrome |
| 12/30/2010 | US20100330673 Methods of making enhanced, autologous fat grafts |
| 12/30/2010 | US20100330182 Tendon Stem Cells |
| 12/30/2010 | US20100330123 Albumin-free botulinum toxin formulations |
| 12/30/2010 | US20100330117 Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis, non-viral based cancers, alzheimers's disease, muscular dystrophy, attention deficit disorder, attention deficit hyperactivity disorder, complex regional pain syndrome, diabetes, neuropathic pain, spider arthritis, west nile virus, fibromyalgia, shingles, gout, migraine headaches, senile dementia, post polio syndrome, central virus deafness, asthma, chronic pain of unknown origin and hepatitis c |
| 12/30/2010 | US20100330072 Myostatin binding agents |
| 12/29/2010 | WO2010151840A2 Albumin-free botulinum toxin formulations |
| 12/29/2010 | WO2010151042A2 Use of schizandra chinensis baillon and chaenomeles sinensis extracts for alleviating muscle fatigue and muscle pain or for enhancing exercise capability |
| 12/29/2010 | EP2267445A1 Methods of detecting small intestinal bacterial overgrowth (SIBO) in a human subject |
| 12/29/2010 | EP2267026A1 Albumin fusion proteins |
| 12/29/2010 | EP2267010A2 Activatable recombinant neurotoxins |
| 12/29/2010 | EP2267009A2 Activatable recombinant neurotoxins |
| 12/29/2010 | EP2267008A2 Activatable recombinant neurotoxins |
| 12/29/2010 | EP2266960A2 Aryl-substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles as anticonvulsants |
| 12/29/2010 | EP2266600A2 Therapeutic composition with a botulinum neurotoxin |
| 12/29/2010 | EP2266599A2 Therapeutic composition with a botulinum neurotoxin |
| 12/29/2010 | EP2265615A1 Imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators |
| 12/29/2010 | EP1530568B1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE |
| 12/29/2010 | EP1197209B1 Percutaneously absorbable preparations |
| 12/29/2010 | CN101932313A Use of hedgehog agonists in the treatment of musculoskeletal-related disorders |
| 12/29/2010 | CN101928329A Tripeptide boric acid (ester) compound and preparation method and application thereof |
| 12/29/2010 | CN101926939A Chinese medicinal preparation for treating rheumatic diseases |
| 12/29/2010 | CN101926903A Chinese medicine preparation for curing facial paralysis |
| 12/29/2010 | CN101926863A Method for identifying Nigella glandulifera Freyn medicinal material |
| 12/29/2010 | CN101926803A Application of quinazoline compounds |
| 12/29/2010 | CN101926802A Application of quinazoline compounds |
| 12/29/2010 | CN101926781A Solid medicinal composition of oxapium iodide |
| 12/29/2010 | CA2766521A1 Albumin-free botulinum toxin formulations |
| 12/28/2010 | USRE42014 Pharmaceutical compositions |
| 12/28/2010 | US7858820 Easy to process and are highly stable on storage; nutraceuticals; dietetics; anions of inner salts contribute to therapeutic and nutritional value of compound; human and animal food/feed supplement; dosage |
| 12/28/2010 | US7858655 synergistic mixtures reduce damage to neurons after a neurodegenerative insult; time-release agents; antiischemic agents; amyotrophic lateral slerosis (ALS), Alzheimer's disease, Parkinson's disease, Hunntington's disease, multiple sclerosis |
| 12/28/2010 | US7858603 neuroprotectants such as 1,4-cholestadien-3-one oxime, used for the treatment of neurodegenerative diseases |
| 12/23/2010 | WO2010148010A1 Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularih 1 (mtm1) polypeptides |
| 12/23/2010 | WO2010147226A1 Pyrazinooxazepine derivatives |
| 12/23/2010 | WO2010146622A1 Nfat signal inhibitor and calcineurin inhibitor |
| 12/23/2010 | US20100324144 Therapy for hyperexcitability disorders |
| 12/23/2010 | US20100324093 Ccr9 inhibitors and methods of use thereof |
| 12/23/2010 | US20100324036 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists |
| 12/23/2010 | US20100323999 Therapeutic Molecules and Methods-1 |
| 12/23/2010 | US20100323993 Uses of pentamidine and related compounds |
| 12/23/2010 | US20100323987 Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
| 12/23/2010 | US20100323981 Treatment of statin side effects |
| 12/23/2010 | US20100323972 Non-immunosuppressive cyclosporin for the treatment of muscular dystrophy |
| 12/23/2010 | US20100323038 Pharmaceutical Compositions |
| 12/23/2010 | US20100323016 Modified release formulation and methods of use |
| 12/23/2010 | US20100322942 Therapeutic and prophylactic methods for neuromuscular disorders |
| 12/22/2010 | EP2264175A1 Fibroblast growth factor homologs |
| 12/22/2010 | EP2264052A2 Activatable recombinant neurotoxins |
| 12/22/2010 | EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors |
| 12/22/2010 | EP2262525A1 Apoaequorin-containing compositions and methods of using same |
| 12/22/2010 | EP1453805B1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 12/22/2010 | EP1392696B1 Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro 2,3-b quinolin-4-yl)-2-(2- oxopyrrolidin -1 -yl)acetamide |
| 12/22/2010 | CN1662242B Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 12/22/2010 | CN101921772A Human antibodies that bind human IL-12 and methods for producing |
| 12/22/2010 | CN101921267A Beta -lactamyl vasopressin Vla antagonists |
| 12/22/2010 | CN101921266A 3,4,6-triaryl-[1,3]-oxazine compound as well as preparation method and application thereof |
| 12/22/2010 | CN101921241A Synthesis of metaxalone with optical activity |
| 12/22/2010 | CN101919801A Solid effervescent mixture for oral absorption |
| 12/21/2010 | CA2426654C 2,4,8-trisubstituted-8h-pyrido[2,3-d}pyrimidin-7-one compounds |
| 12/21/2010 | CA2395100C Substituted sapogenins and their use |
| 12/16/2010 | WO2010093784A3 Modified virus vectors and methods of making and using the same |
| 12/16/2010 | US20100317699 Use of hedgehog agonists in the treatment of musculoskeletal-related disorders |
| 12/16/2010 | US20100317635 Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators |
| 12/16/2010 | US20100316706 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 12/16/2010 | US20100316644 Truncated actriib-fc fusion proteins |
| 12/16/2010 | US20100316624 Treatment of fibroses and liver disorders |
| 12/15/2010 | EP2260903A1 C-19 steroids for therapeutic uses |
| 12/15/2010 | EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof |
| 12/15/2010 | CN101918366A Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 12/15/2010 | CN101912670A 热能袋 Thermal Bags |
| 12/15/2010 | CN101912454A Medicament for treating lumbago and preparation method thereof |
| 12/15/2010 | CN101912392A Pharmaceutical compositions comprising colloidal silicon dioxide |
| 12/14/2010 | US7851589 Polypeptide derived from the ryanodine receptor that inhibits calcium leakage |
| 12/14/2010 | US7851484 Certain chemical entities, compositions, and methods |
| 12/14/2010 | US7851181 Generating monoclonal antibodies specific to insulin-like growth factor receptor-I (IGFR1) for use in treatment and prevention of cell proliferative disorders |
| 12/14/2010 | US7850991 Calcium formate for use as a dietary supplement |
| 12/14/2010 | US7850968 Cluster of differentiation 83 specific immunoglobulin for use in treatment of autoimmune and neoplastic disorders |
| 12/09/2010 | WO2010140685A1 Heterocyclic compound and hematopoietic stem cell amplifier |
| 12/09/2010 | US20100311840 Oral formulations of bis(thiohydrazide amides) |
| 12/09/2010 | US20100311812 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/09/2010 | US20100311780 Nitric oxide amino acid ester compound, composition for increasing nitirc oxide levels and method of use |
| 12/09/2010 | US20100311778 Chromane derivatives as trpv3 modulators |
| 12/09/2010 | US20100311189 Novel Receptor Nucleic Acids and Polypeptides |
| 12/09/2010 | US20100310634 Transdermal therapeutic system having urea components |
| 12/09/2010 | US20100310574 Methods and compositions for the treatment and diagnosis of statin-induced myopathy |